Ulrich Gueller
Contrast-enhanced ultrasound can guide the therapeutic strategy by improving the detection of colorectal liver metastases
Sawatzki M, Gueller U, Güsewell S, Husarik D, Semela D, Brand S. Contrast-enhanced ultrasound can guide the therapeutic strategy by improving the detection of colorectal liver metastases. J Hepatol 2021; 74:419-427.
Feb 12, 2021Contrast-enhanced ultrasound can guide the therapeutic strategy by improving the detection of colorectal liver metastases
Feb 12, 2021J Hepatol 2021; 74:419-427
Sawatzki Mikael, Gueller Ulrich, Güsewell Sabine, Husarik Daniela B., Semela David, Brand Stephan
Molecular Lymph Node Staging with One-Step Nucleic Acid Amplification and its Prognostic Value for Patients with Colon Cancer: The First Follow-up Study
Weixler B, Viehl C, Van de Velde C, Vahrmeijer A, Zettl A, Gueller U, Demartines N, Warschkow R, Teixeira da Cunha S, Zuber M. Molecular Lymph Node Staging with One-Step Nucleic Acid Amplification and its Prognostic Value for Patients with Colon Cancer: The First Follow-up Study. World J Surg 2021; 45:1526-1536.
Jan 29, 2021Molecular Lymph Node Staging with One-Step Nucleic Acid Amplification and its Prognostic Value for Patients with Colon Cancer: The First Follow-up Study
Jan 29, 2021World J Surg 2021; 45:1526-1536
Weixler Benjamin, Viehl Carsten T, Van de Velde Cornelis J H, Vahrmeijer Alexander, Zettl Andreas, Gueller Ulrich, Demartines Nicolas, Warschkow Rene, Teixeira da Cunha Sofia, Zuber Markus
Improved quality of colon cancer surveillance after implementation of a personalized surveillance schedule
Rueff J, Weixler B, Viehl C, Ochsner A, Warschkow R, Gueller U, Mingrone W, Zuber M. Improved quality of colon cancer surveillance after implementation of a personalized surveillance schedule. J Surg Oncol 2020
May 14, 2020Improved quality of colon cancer surveillance after implementation of a personalized surveillance schedule
May 14, 2020J Surg Oncol 2020
Rueff Jessica, Weixler Benjamin, Viehl Carsten T, Ochsner Alex, Warschkow Rene, Gueller Ulrich, Mingrone Walter, Zuber Markus
Population-based SEER analysis of survival in colorectal cancer patients with or without resection of lung and liver metastases
Siebenhüner A, Gueller U, Warschkow R. Population-based SEER analysis of survival in colorectal cancer patients with or without resection of lung and liver metastases. BMC cancer 2020; 20:246.
Mar 23, 2020Population-based SEER analysis of survival in colorectal cancer patients with or without resection of lung and liver metastases
Mar 23, 2020BMC cancer 2020; 20:246
Siebenhüner Alexander R, Gueller Ulrich, Warschkow Rene
Prolonged tumor response associated with sequential immune checkpoint inhibitor combination treatment and regorafenib in a patient with advanced pretreated hepatocellular carcinoma
Jörger M, Gueller U, Bastian S, Driessen C, von Moos R. Prolonged tumor response associated with sequential immune checkpoint inhibitor combination treatment and regorafenib in a patient with advanced pretreated hepatocellular carcinoma. J Gastrointest Oncol 2019; 10:373-378.
Apr 1, 2019Prolonged tumor response associated with sequential immune checkpoint inhibitor combination treatment and regorafenib in a patient with advanced pretreated hepatocellular carcinoma
Apr 1, 2019J Gastrointest Oncol 2019; 10:373-378
Jörger Markus, Gueller Ulrich, Bastian Sara, Driessen Christoph, von Moos Roger
Screening and surveillance in hereditary gastrointestinal cancers: Recommendations from the European Society of Digestive Oncology (ESDO) expert discussion at the 20th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona, June 2018
Vangala D, Matysiak-Budnik T, van Laethem J, Ducreux M, Hammel P, Carneiro F, Castells A, Gueller U, van Cutsem E, Wyrwicz L, Balmaña J, Cauchin E, Schmiegel W. Screening and surveillance in hereditary gastrointestinal cancers: Recommendations from the European Society of Digestive Oncology (ESDO) expert discussion at the 20th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona, June 2018. Eur J Cancer 2018; 104:91-103.
Oct 18, 2018Screening and surveillance in hereditary gastrointestinal cancers: Recommendations from the European Society of Digestive Oncology (ESDO) expert discussion at the 20th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona, June 2018
Oct 18, 2018Eur J Cancer 2018; 104:91-103
Vangala Deepak B, Matysiak-Budnik Tamara, van Laethem Jean-Luc, Ducreux Michel, Hammel Pascal, Carneiro Fatima, Castells Antoni, Gueller Ulrich, van Cutsem Eric, Wyrwicz Lucian, Balmaña Judith, Cauchin Estelle, Schmiegel Wolff
Lymph node ratio is inferior to pN-stage in predicting outcome in colon cancer patients with high numbers of analyzed lymph nodes
Jakob M, Gueller U, Ochsner A, Oertli D, Zuber M, Viehl C. Lymph node ratio is inferior to pN-stage in predicting outcome in colon cancer patients with high numbers of analyzed lymph nodes. BMC Surg 2018; 18:81.
Oct 3, 2018Lymph node ratio is inferior to pN-stage in predicting outcome in colon cancer patients with high numbers of analyzed lymph nodes
Oct 3, 2018BMC Surg 2018; 18:81
Jakob Manuel O, Gueller Ulrich, Ochsner Alex, Oertli Daniel, Zuber Markus, Viehl Carsten T
The prognostic value of signet ring cell histology in stage I/II colon cancer-a population-based, propensity score-matched analysis
Ackermann C, Gueller U, Jochum W, Schmied B, Warschkow R. The prognostic value of signet ring cell histology in stage I/II colon cancer-a population-based, propensity score-matched analysis. Int J Colorectal Dis 2018
Jun 7, 2018The prognostic value of signet ring cell histology in stage I/II colon cancer-a population-based, propensity score-matched analysis
Jun 7, 2018Int J Colorectal Dis 2018
Ackermann Christoph Jakob, Gueller Ulrich, Jochum Wolfram, Schmied Bruno, Warschkow Rene
Clinical relevance of molecular diagnostics in gastrointestinal (GI) cancer: European Society of Digestive Oncology (ESDO) expert discussion and recommendations from the 17th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona
Baraniskin A, Seufferlein T, van Cutsem E, Carneiro F, Ducreux M, Gruenberger T, Matysiak-Budnik T, Wasan H, Gueller U, Wyrwicz L, van Laethem J, Schmiegel W. Clinical relevance of molecular diagnostics in gastrointestinal (GI) cancer: European Society of Digestive Oncology (ESDO) expert discussion and recommendations from the 17th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona. Eur J Cancer 2017; 86:305-317.
Oct 21, 2017Clinical relevance of molecular diagnostics in gastrointestinal (GI) cancer: European Society of Digestive Oncology (ESDO) expert discussion and recommendations from the 17th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona
Oct 21, 2017Eur J Cancer 2017; 86:305-317
Baraniskin Alexander, Seufferlein Thomas, van Cutsem Eric, Carneiro Fatima, Ducreux Michel, Gruenberger Thomas, Matysiak-Budnik Tamara, Wasan Harpreet S, Gueller Ulrich, Wyrwicz Lucjan, van Laethem Jean-Luc, Schmiegel Wolff
Sentinel Lymph Node Mapping with Isosulfan Blue or Indocyanine Green in Colon Cancer Shows Comparable Results and Identifies Patients with Decreased Survival: A Prospective Single-Center Trial
Weixler B, Rickenbacher A, Raptis D, Viehl C, Gueller U, Rueff J, Zettl A, Zuber M. Sentinel Lymph Node Mapping with Isosulfan Blue or Indocyanine Green in Colon Cancer Shows Comparable Results and Identifies Patients with Decreased Survival: A Prospective Single-Center Trial. World J Surg 2017; 41:2378-2386.
Sep 1, 2017Sentinel Lymph Node Mapping with Isosulfan Blue or Indocyanine Green in Colon Cancer Shows Comparable Results and Identifies Patients with Decreased Survival: A Prospective Single-Center Trial
Sep 1, 2017World J Surg 2017; 41:2378-2386
Weixler Benjamin, Rickenbacher Andreas, Raptis Dimitri Aristotle, Viehl Carsten T, Gueller Ulrich, Rueff Jessica, Zettl Andreas, Zuber Markus
Lower hospital volume is associated with higher mortality after oesophageal, gastric, pancreatic and rectal cancer resection
Gueller U, Warschkow R, Ackermann C, Schmied B, Cerny T, ess s. Lower hospital volume is associated with higher mortality after oesophageal, gastric, pancreatic and rectal cancer resection. Swiss Med Wkly 2017; 147:w14473.
Jul 27, 2017Lower hospital volume is associated with higher mortality after oesophageal, gastric, pancreatic and rectal cancer resection
Jul 27, 2017Swiss Med Wkly 2017; 147:w14473
Gueller Ulrich, Warschkow Rene, Ackermann Christoph Jakob, Schmied Bruno, Cerny Thomas, ess silvia
Comparative Analysis of Tumor Cell Dissemination to the Sentinel Lymph Nodes and to the Bone Marrow in Patients With Nonmetastasized Colon Cancer: A Prospective Multicenter Study
Weixler B, Viehl C, Warschkow R, Gueller U, Ramser M, Sauter R, Zuber M. Comparative Analysis of Tumor Cell Dissemination to the Sentinel Lymph Nodes and to the Bone Marrow in Patients With Nonmetastasized Colon Cancer: A Prospective Multicenter Study. JAMA Surg 2017
Jun 7, 2017Comparative Analysis of Tumor Cell Dissemination to the Sentinel Lymph Nodes and to the Bone Marrow in Patients With Nonmetastasized Colon Cancer: A Prospective Multicenter Study
Jun 7, 2017JAMA Surg 2017
Weixler Benjamin, Viehl Carsten T, Warschkow Rene, Gueller Ulrich, Ramser Michaela, Sauter Rafael, Zuber Markus
Presence of bone marrow micro-metastases in stage I-III colon cancer patients is associated with worse disease-free and overall survival
Viehl C, Oertli D, Sauter G, Terracciano L, Langer I, Banz V, Ramser M, Rosenthal R, Dell-Kuster S, Gueller U, Weixler B, Zuber M. Presence of bone marrow micro-metastases in stage I-III colon cancer patients is associated with worse disease-free and overall survival. Cancer Med 2017; 6:918-927.
Apr 12, 2017Presence of bone marrow micro-metastases in stage I-III colon cancer patients is associated with worse disease-free and overall survival
Apr 12, 2017Cancer Med 2017; 6:918-927
Viehl Carsten T, Oertli Daniel, Sauter Guido, Terracciano Luigi, Langer Igor, Banz Vanessa, Ramser Michaela, Rosenthal Rachel, Dell-Kuster Salome, Gueller Ulrich, Weixler Benjamin, Zuber Markus
Palliative Primary Tumor Resection in Patients With Metastatic Colorectal Cancer: For Whom and When?
Tarantino I, Warschkow R, Gueller U. Palliative Primary Tumor Resection in Patients With Metastatic Colorectal Cancer: For Whom and When?. Ann Surg 2017; 265:e59-e60.
Apr 1, 2017Palliative Primary Tumor Resection in Patients With Metastatic Colorectal Cancer: For Whom and When?
Apr 1, 2017Ann Surg 2017; 265:e59-e60
Tarantino Ignazio, Warschkow Rene, Gueller Ulrich
Early Postoperative FDG-PET-CT Imaging Results in a Relevant Upstaging in the pN2 Subgroup of Stage III Colorectal Cancer Patients
Fehr M, Müller J, Knitel M, Fornaro J, Horber D, Koeberle D, Cerny T, Gueller U. Early Postoperative FDG-PET-CT Imaging Results in a Relevant Upstaging in the pN2 Subgroup of Stage III Colorectal Cancer Patients. Clin Colorectal Cancer 2017
Mar 21, 2017Early Postoperative FDG-PET-CT Imaging Results in a Relevant Upstaging in the pN2 Subgroup of Stage III Colorectal Cancer Patients
Mar 21, 2017Clin Colorectal Cancer 2017
Fehr Martin, Müller Joachim, Knitel Meinhard, Fornaro Jürgen, Horber Daniel, Koeberle Dieter, Cerny Thomas, Gueller Ulrich
Secondary malignancies after rectal cancer resection with and without radiation therapy: A propensity-adjusted, population-based SEER analysis
Warschkow R, Gueller U, Cerny T, Schmied B, Plasswilm L, Putora P. Secondary malignancies after rectal cancer resection with and without radiation therapy: A propensity-adjusted, population-based SEER analysis. Radiother Oncol 2017; 123:139-146.
Mar 9, 2017Secondary malignancies after rectal cancer resection with and without radiation therapy: A propensity-adjusted, population-based SEER analysis
Mar 9, 2017Radiother Oncol 2017; 123:139-146
Warschkow Rene, Gueller Ulrich, Cerny Thomas, Schmied Bruno, Plasswilm Ludwig, Putora Paul Martin
Better survival in right-sided versus left-sided stage I - III colon cancer patients
Warschkow R, Sulz M, Marti L, Tarantino I, Schmied B, Cerny T, Gueller U. Better survival in right-sided versus left-sided stage I - III colon cancer patients. BMC cancer 2016; 16:554.
Jul 28, 2016Better survival in right-sided versus left-sided stage I - III colon cancer patients
Jul 28, 2016BMC cancer 2016; 16:554
Warschkow Rene, Sulz Michael, Marti Lukas, Tarantino Ignazio, Schmied Bruno, Cerny Thomas, Gueller Ulrich
Improved Survival After Primary Tumor Surgery in Metastatic Breast Cancer: A Propensity-adjusted, Population-based SEER Trend Analysis
Warschkow R, Gueller U, Tarantino I, Cerny T, Schmied B, Thürlimann B, Jörger M. Improved Survival After Primary Tumor Surgery in Metastatic Breast Cancer: A Propensity-adjusted, Population-based SEER Trend Analysis. Ann Surg 2016; 263:1188-98.
Jun 1, 2016Improved Survival After Primary Tumor Surgery in Metastatic Breast Cancer: A Propensity-adjusted, Population-based SEER Trend Analysis
Jun 1, 2016Ann Surg 2016; 263:1188-98
Warschkow Rene, Gueller Ulrich, Tarantino Ignazio, Cerny Thomas, Schmied Bruno, Thürlimann Beat, Jörger Markus
A population-based analysis of secondary malignancies in breast cancer patients receiving breast reconstruction
Warschkow R, Cerny T, Schmied B, Gueller U, Thürlimann B, Jörger M. A population-based analysis of secondary malignancies in breast cancer patients receiving breast reconstruction. Br J Cancer 2016; 115:80-4.
May 17, 2016A population-based analysis of secondary malignancies in breast cancer patients receiving breast reconstruction
May 17, 2016Br J Cancer 2016; 115:80-4
Warschkow Rene, Cerny Thomas, Schmied Bruno, Gueller Ulrich, Thürlimann Beat, Jörger Markus
Predictive Value of CEA for Survival in Stage I Rectal Cancer: a Population-Based Propensity Score-Matched Analysis
Tarantino I, Warschkow R, Schmied B, Gueller U, Mieth M, Cerny T, Büchler M, Ulrich A. Predictive Value of CEA for Survival in Stage I Rectal Cancer: a Population-Based Propensity Score-Matched Analysis. J Gastrointest Surg 2016; 20:1213-22.
Apr 11, 2016Predictive Value of CEA for Survival in Stage I Rectal Cancer: a Population-Based Propensity Score-Matched Analysis
Apr 11, 2016J Gastrointest Surg 2016; 20:1213-22
Tarantino Ignazio, Warschkow Rene, Schmied Bruno, Gueller Ulrich, Mieth Markus, Cerny Thomas, Büchler Markus W, Ulrich Alexis